REQUEST A DEMO
Total
USD $0.00
Search more companies

Cirugia Vascular Y Cardio Neuro Endovascular Tobar Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Pharmacies and Drug Stores | Diagnostic Imaging Centers | Other Ambulatory Health Care Services
Full name: Cirugia Vascular Y Cardio Neuro Endovascular Tobar Sas Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Cirugia Vascular Y Cardio Neuro Endovascular Tobar Sas is a company in Colombia, with a head office in Popayan. The enterprise currently operates in the Ambulatory Health Care Services sector. It was incorporated on August 16, 2016. The company’s latest financial report indicates a net sales revenue increase of 140.69% in 2023. There was a total growth of 55.15% in Cirugia Vascular Y Cardio Neuro Endovascular Tobar Sas’s total assets over the same period. The net profit margin of Cirugia Vascular Y Cardio Neuro Endovascular Tobar Sas decreased by 10% in 2023.

Headquarters
Cl 18 A N Cr 5 30Cs 604
Popayan; Cauca;

Contact Details: Purchase the Cirugia Vascular Y Cardio Neuro Endovascular Tobar Sas report to view the information.

Basic Information
Outstanding Shares:
Purchase the Cirugia Vascular Y Cardio Neuro Endovascular Tobar Sas report to view the information.
Incorporation Date:
August 16, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Cirugia Vascular Y Cardio Neuro Endovascular Tobar Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
140.69%
Total operating revenue
140.69%
Operating profit (EBIT)
56.64%
EBITDA
54.06%
Net Profit (Loss) for the Period
41.45%
Total assets
55.15%
Total equity
35.57%
Operating Profit Margin (ROS)
-9.39%
Net Profit Margin
-10%
Return on Equity (ROE)
1.52%
Debt to Equity Ratio
10.12%
Quick Ratio
-1.51%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?